Keyphrases
Diabetic Nephropathy
100%
Type 2 Diabetic Patients
54%
Type 1 Diabetes Mellitus (T1DM)
51%
Type I Diabetes
46%
Microalbuminuria
43%
Albuminuria
40%
Type 1 Diabetic Patient
38%
Glomerular Filtration Rate
35%
Nephropathy
33%
Type 2 Diabetes Mellitus (T2DM)
28%
Diabetic Patients
21%
Kidney Function
21%
Insulin Independence
21%
All-cause Mortality
20%
Urinary Albumin Excretion
17%
Cardiovascular Disease
16%
Albumin
14%
Cardiovascular Mortality
14%
End-stage Renal Disease
14%
Losartan
13%
Blood Pressure
12%
Diabetic
12%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
11%
Diabetes
11%
Antihypertensive Treatment
11%
Normoalbuminuria
11%
Aliskiren
10%
Hypertensive
10%
Hemoglobin A1c (HbA1c)
10%
Chronic Kidney Disease
9%
Placebo
9%
Endothelial Dysfunction
9%
Arterial Blood Pressure
9%
Polymorphism
8%
Atrasentan
8%
Diabetic Kidney Disease
8%
Diabetes Duration
8%
Estimated Glomerular Filtration Rate
7%
Cardiovascular Events
7%
Irbesartan
7%
Renoprotective Effect
7%
Angiotensin Receptor Blockers
7%
Severe Hypoglycemia
7%
Risk Factors
7%
Genotype
7%
Incident Cardiovascular Disease
7%
Systolic Blood Pressure
7%
Hazard Ratio
7%
Lisinopril
7%
Decline Rate
6%
Medicine and Dentistry
Diabetic Nephropathy
75%
Diabetes Mellitus
60%
Insulin Dependent Diabetes Mellitus
34%
Nephropathy
30%
Glomerular Filtration Rate
28%
Microalbuminuria
24%
Albuminuria
24%
Maturity Onset Diabetes of the Young
21%
Kidney Function
20%
Diabetes
20%
Urinary System
19%
Patient with Type 2 Diabetes
19%
Cardiovascular System
18%
Cardiovascular Disease
16%
Patient with Type 1 Diabetes
14%
Blood Pressure
14%
End Stage Renal Disease
11%
All Cause Mortality
10%
Antihypertensive Therapy
10%
Arterial Pressure
7%
Endothelial Dysfunction
6%
Placebo
6%
Dipeptidyl Carboxypeptidase
5%
Hazard Ratio
5%
Biological Marker
5%
Autoregulation
5%
Amino Terminal Sequence
5%
Post-Hoc Analysis
5%
Hemoglobin A1c
5%
Microangiopathy
5%
Creatinine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Nephropathy
71%
Diabetes Mellitus
51%
Non Insulin Dependent Diabetes Mellitus
50%
Insulin Dependent Diabetes Mellitus
40%
Albuminuria
29%
Kidney Disease
26%
Microalbuminuria
24%
Cardiovascular Disease
21%
All Cause Mortality
19%
Placebo
13%
Losartan
12%
Antihypertensive Agent
12%
End Stage Renal Disease
11%
Aliskiren
9%
Creatinine
9%
Chronic Kidney Failure
9%
Atrasentan
8%
Renin
8%
Angiotensin
8%
Irbesartan
7%
Cardiovascular Mortality
7%
Angiotensin Receptor Antagonist
7%
Hypoglycemia
7%
Endothelial Dysfunction
6%
Lisinopril
6%
Biological Marker
5%
Deterioration
5%
Inflammation
5%
Hemoglobin A1c
5%
Dipeptidyl Carboxypeptidase
5%
